RBOT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Vicarious Surgical Inc (RBOT) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive financial performance, absence of trading trends, and no significant news or catalysts make it a hold. The technical indicators are neutral, and there are no proprietary trading signals to suggest immediate action.
The MACD is slightly positive at 0.0416, indicating mild bullish momentum, but it is contracting. RSI is neutral at 51.92, showing no overbought or oversold conditions. Moving averages are converging, suggesting indecision in price direction. Key support is at 1.76, and resistance is at 2.294.
NULL. There are no recent news events, no significant hedge fund or insider activity, and no congress trading data.
Revenue remains at 0, and gross margin is stagnant. The market cap is very low at $14.52M, indicating a high-risk investment.
For Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$11.058M, down -35.30% YoY. EPS declined to -1.86, down -35.86% YoY. Gross margin remained at 0, showing no improvement.
No recent analyst rating or price target updates are available for RBOT.
